NCT05346016

Brief Summary

Investigators will recruit up to 4-generations of human family cohorts, in order to characterize the microbiome and its changes across different generations.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 18, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 20, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 26, 2022

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

June 15, 2025

Status Verified

June 1, 2025

Enrollment Period

4 years

First QC Date

April 20, 2022

Last Update Submit

June 13, 2025

Conditions

Keywords

gut microbiomemicrobial adaptationmicrobial evolution

Outcome Measures

Primary Outcomes (1)

  • Characterizing microbial transfers in multigenerational families and subsequent stability of microbial colonization.

    High-resolution metagenomics of strains tracked over time in individuals and families, relative to collected metadata (family closeness, medical history, etc) Associating microbiome stability to human genetic loci.

    2026

Secondary Outcomes (1)

  • Characterizing gut microbial evolution and adaptation in human host families.

    2026

Other Outcomes (2)

  • Describing the prokaryotic and eukaryotic genome-level diversity within the human gut

    2024

  • Identify predictors of within-family gut microbe transfer rates

    2026

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Investigators are recruiting the family members of PEARL (ClinicalTrials.gov ID: NCT03916874) study participants, a longitudinal study to understand how gut microbes contribute to maintaining health during pregnancy and early life already underway at QIB (Quadram Institute Bioscience). Investigators will extend this cohort, by recruiting family members of the PEARL mother to form the PEARL-AGE cohort, extending it from two generations to four generations.

You may qualify if:

  • Husband/partner of a PEARL mother, their biological parents and grandparents.
  • PEARL mother's biological parents and grandparents (great-grandparents to the PEARL baby).
  • Co-habiting non-biological fathers of the baby such as stepfathers and partners of the PEARL mother, their parents and grandparents.
  • A biological sibling of the PEARL baby or a step-sibling who is currently co-habiting with the PEARL baby.
  • Adult participants must be able to consent for themselves and able to understand the questionnaire.
  • Child participants must have a parent and/or guardian to provide assent on their behalf.
  • Must be living in England.
  • Must be willing to accommodate a small cool box to store and transport the biological samples until they are collected, if not having immediate access to the PEARL study freezer.
  • Vulnerable participants such as participants with mild cognitive impairment may be included as long as they have full support from their family members.

You may not qualify if:

  • Not related/affiliated to a mother currently participating in the PEARL study, or the cohabiting partner, or father of the PEARL infant. If a PEARL participant has withdrawn from the PEARL study or is no longer participating, investigators will not approach the PEARL participant for recruitment of their family members.
  • Step-fathers or long-term partners that have been cohabiting with the PEARL mother for less than three months.
  • Those currently in prison.
  • Those who are unable to provide written informed consent.
  • Living with or related to a member of the Research Study team.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Quadram Institute Biosciences

Norwich, Norfolk, NR4 7UQ, United Kingdom

Location

Biospecimen

Retention: SAMPLES WITH DNA

Faecal samples will be collected from the participants.

Study Officials

  • Falk Hildebrand, PhD

    Quadram Institute Bioscience

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2022

First Posted

April 26, 2022

Study Start

March 18, 2022

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

June 15, 2025

Record last verified: 2025-06

Locations